DEF 14AThe Ballot
Travere Therapeutics, Inc. files DEF 14A
Filed Apr 1, 2025 · 1y ago · Accession 0001438533-25-000016
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- DEF 14A
- Filing date
- Apr 1, 2025
- Report date
- May 15, 2025
- Document
- tvtx-20250331.htm
- Size
- 3.9 MB